Amibo Health Gets FDA Approval For its Suite of Home Monitoring Devices

8-4-2013 10-54-42 PM

Stanford, Conn.-based Ambio Health wins class-11 510(k) FDA approval for a series of home monitoring devices that allows patients to track weight, blood pressure, and glucose. The devices connect via Bluetooth to a central gateway which publishes the data to the Ambio Care Portal, where patients, caregivers, and physicians can review and trend the data.

“Our goal at Ambio is to enable individuals to take health readings at home and get connected to health care providers, loved ones and caregivers who may not be able to visit every day. We are very pleased to have realized the important milestone of FDA 510(k) clearance so quickly as it means we will be able to make this product readily available to those who need it.”  – Kevin Jones, CEO of Ambio Health. “

Amibo’s remote health monitoring system was launched in January at the 2013 CES tradeshow. The FDA certified platform will be presented later this week at the 2013 American Association of Diabetes Educators Annual Meeting.

↑ Back to top

Founding Sponsors

Platinum Sponsors